CAR T-Cell Therapy Market worth $13.78 billion by 2031 | MarketsandMarkets™
Autolus Therapeutics plc - American Depositary Shares (AUTL)
Last autolus therapeutics plc - american depositary shares earnings: 11/7 07:06 am
Check Earnings Report
US:NASDAQ Investor Relations:
autolus.com/investor-relations
Company Research
Source: PR Newswire
DELRAY BEACH, Fla., Feb. 16, 2026 /PRNewswire/ -- According to MarketsandMarkets™, the CAR T-Cell Therapy Market is estimated to reach USD 13.78 billion by 2031 from USD 7.24 billion in 2026, at a CAGR of 13.7%.Browse 300 market data Tables and 30 Figures spread through 280 Pages and in-depth TOC on "CAR T-Cell Therapy Market - Global Forecast to 2031"CAR T-Cell Therapy Market Size & Forecast:Market Size Available for Years: 2024–20302026 Market Size: USD 7.24 billion2031 Projected Market Size: USD 13.78 billionCAGR (2026–2031): 13.7%CAR T-Cell Therapy Market Trends & Insights:The North America CAR T- cell therapy market accounted for a 67.7% revenue share in 2025.By product, the YESCARTA segment is expected to dominate the market, with a share of 25.3% in 2025.By target, the CD19 segment is expected to dominate the market, with a share of 62.3%.By indication, multiple myeloma dominated the CAR T- cell therapy market.By demographics, the adult segment is expected to dominate the marke
Show less
Read more
Impact Snapshot
Event Time:
AUTL
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
AUTL alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
AUTL alerts
High impacting Autolus Therapeutics plc - American Depositary Shares news events
Weekly update
A roundup of the hottest topics
AUTL
News
- Autolus Therapeutics (NASDAQ:AUTL) is now covered by analysts at HC Wainwright. They set a "buy" rating on the stock.MarketBeat
- CAR T-Cell Therapy Market worth $13.78 billion by 2031 | MarketsandMarkets™PR Newswire
- Autolus Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)GlobeNewswire
- Autolus Therapeutics (NASDAQ:AUTL) was downgraded by analysts at Zacks Research from a "hold" rating to a "strong sell" rating.MarketBeat
- Autolus Therapeutics (NASDAQ:AUTL) had its "sell (d-)" rating reaffirmed by analysts at <a style="font-weight:bold" href="https://weissratings.com/">Weiss Ratings</a>.MarketBeat
AUTL
Earnings
- 11/12/25 - Miss
AUTL
Sec Filings
- 2/17/26 - Form SCHEDULE
- 2/13/26 - Form SCHEDULE
- 1/26/26 - Form 424B3
- AUTL's page on the SEC website